Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.

Boyd, Ben J;Bergström, Christel A S;Vinarov, Zahari;Kuentz, Martin;Jannin, Vincent;et.al.
(2019) European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences — Vol. 137, p. 104967 (2019)

Files

No attached file found for this publication.

Details

Authors
  • Boyd, Ben J
    Author
  • Bergström, Christel A S
    Author
  • Vinarov, Zahari
    Author
  • Kuentz, Martin
    Author
  • Shrestha, NehaUCLouvain
    Author
  • Préat, VéroniqueUCLouvain
    Author
  • Jannin, Vincent
    Author
Show more
Abstract
Poorly water-soluble drugs continue to be a problematic, yet important class of pharmaceutical compounds for treatment of a wide range of diseases. Their prevalence in discovery is still high, and their development is usually limited by our lack of a complete understanding of how the complex chemical, physiological and biochemical processes that occur between administration and absorption individually and together impact on bioavailability. This review defines the challenge presented by these drugs, outlines contemporary strategies to solve this challenge, and consequent in silico and in vitro evaluation of the delivery technologies for poorly water-soluble drugs. The next steps and unmet needs are proposed to present a roadmap for future studies for the field to consider enabling progress in delivery of poorly water-soluble compounds.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., Müllertz, A., Bauer-Brandl, A., & Jannin, V. (2019). Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 137, 104967. https://doi.org/10.1016/j.ejps.2019.104967 (Original work published 2019)